CENTESSA PHARMACEUTICALS PLC Increase (Decrease) in Accrued Liabilities
CENTESSA PHARMACEUTICALS PLC reported Increase (Decrease) in Accrued Liabilities of -$9.02 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-05-05
- CENTESSA PHARMACEUTICALS PLC increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was -$9.02M.
- CENTESSA PHARMACEUTICALS PLC increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was $12.14M, a 62.91% decline year-over-year.
- CENTESSA PHARMACEUTICALS PLC increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was -$689.00K.
- CENTESSA PHARMACEUTICALS PLC increase (decrease) in accrued liabilities for the quarter ending 2025-06-30 was $2.88M, a 12.24% decline year-over-year.
- CENTESSA PHARMACEUTICALS PLC increase (decrease) in accrued liabilities for fiscal 2025 was -$15.22M, a 166.82% decline from fiscal 2024.
- CENTESSA PHARMACEUTICALS PLC increase (decrease) in accrued liabilities for fiscal 2024 was $22.77M.
- CENTESSA PHARMACEUTICALS PLC increase (decrease) in accrued liabilities for fiscal 2023 was -$797.00K, a 112.73% decline from fiscal 2022.
- CENTESSA PHARMACEUTICALS PLC increase (decrease) in accrued liabilities for fiscal 2022 was $6.26M.
| Period end | Increase (Decrease) in Accrued Liabilities 1 month | Increase (Decrease) in Accrued Liabilities 2 month | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 5 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 8 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 11 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | -$9.02M 10-Q · filed 2026-05-05 | $3.13M derived: sum of 2 quarters · filed 2026-05-05 | $2.44M derived: sum of 3 quarters · filed 2026-05-05 | $5.32M derived: sum of 4 quarters · filed 2026-05-05 | |||||
| 2025-12-31 | $12.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $11.45M derived: sum of 2 quarters · filed 2026-03-31 | $14.33M derived: sum of 3 quarters · filed 2026-03-31 | -$15.22M 10-K · filed 2026-03-31 | |||||
| 2025-09-30 | -$689.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $2.19M derived: sum of 2 quarters · filed 2025-11-05 | -$27.36M 10-Q · filed 2025-11-05 | $5.38M derived: sum of 4 quarters · filed 2026-05-05 | |||||
| 2025-06-30 | $2.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$26.67M 10-Q · filed 2025-08-12 | $6.07M derived: sum of 3 quarters · filed 2026-05-05 | $2.23M derived: sum of 4 quarters · filed 2026-05-05 | |||||
| 2025-03-31 | -$29.55M 10-Q · filed 2026-05-05 | $3.18M derived: sum of 2 quarters · filed 2026-05-05 | -$647.00K derived: sum of 3 quarters · filed 2026-05-05 | $2.64M derived: sum of 4 quarters · filed 2026-05-05 | |||||
| 2024-12-31 | $32.73M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $28.90M derived: sum of 2 quarters · filed 2026-03-31 | $32.19M derived: sum of 3 quarters · filed 2026-03-31 | $22.77M 10-K · filed 2026-03-31 | |||||
| 2024-09-30 | -$3.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$548.00K derived: sum of 2 quarters · filed 2025-11-05 | -$9.96M 10-Q · filed 2025-11-05 | -$7.92M derived: sum of 4 quarters · filed 2025-11-05 | |||||
| 2024-06-30 | $3.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$6.13M 10-Q · filed 2025-08-12 | -$4.09M derived: sum of 3 quarters · filed 2025-08-12 | -$3.94M derived: sum of 4 quarters · filed 2025-08-12 | |||||
| 2024-03-31 | -$9.41M 10-Q · filed 2025-05-14 | -$7.37M derived: sum of 2 quarters · filed 2025-05-14 | -$7.22M derived: sum of 3 quarters · filed 2025-05-14 | -$444.00K derived: sum of 4 quarters · filed 2025-05-14 | |||||
| 2023-12-31 | $2.04M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $2.19M derived: sum of 2 quarters · filed 2025-03-24 | $8.97M derived: sum of 3 quarters · filed 2025-03-24 | -$797.00K 10-K · filed 2025-03-24 | |||||
| 2023-09-30 | $147.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $6.93M derived: sum of 2 quarters · filed 2024-11-12 | -$2.84M 10-Q · filed 2024-11-12 | -$7.67M derived: sum of 4 quarters · filed 2024-11-12 | |||||
| 2023-06-30 | $6.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$2.99M 10-Q · filed 2024-08-13 | -$7.82M derived: sum of 3 quarters · filed 2024-08-13 | -$4.68M derived: sum of 4 quarters · filed 2024-08-13 | |||||
| 2023-03-31 | -$9.77M 10-Q · filed 2024-05-13 | -$14.60M derived: sum of 2 quarters · filed 2024-05-13 | -$11.46M derived: sum of 3 quarters · filed 2024-05-13 | -$6.10M derived: sum of 4 quarters · filed 2024-05-13 | |||||
| 2022-12-31 | -$4.83M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$1.70M derived: sum of 2 quarters · filed 2024-03-28 | $3.67M derived: sum of 3 quarters · filed 2024-03-28 | $6.26M 10-K · filed 2024-03-28 | |||||
| 2022-09-30 | $3.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $8.51M derived: sum of 2 quarters · filed 2023-11-13 | $11.10M 10-Q · filed 2023-11-13 | ||||||
| 2022-06-30 | $5.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $7.96M 10-Q · filed 2023-08-14 | |||||||
| 2022-03-31 | $2.59M 10-Q · filed 2023-05-12 | ||||||||
| 2021-12-31 | $12.97M 10-K · filed 2023-03-30 | ||||||||
| 2021-09-30 | $7.63M 10-Q · filed 2022-11-10 | ||||||||
| 2021-06-30 | $4.71M 10-Q · filed 2022-08-10 | ||||||||
| 2021-03-31 | $998.00K 10-Q · filed 2022-05-16 | ||||||||
| 2021-01-29 | -$589.00K 10-K · filed 2023-03-30 | ||||||||
| 2020-12-31 | $684.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $623.00K derived: sum of 2 quarters · filed 2022-03-30 | $653.00K 10-K · filed 2022-03-30 | ||||||
| 2020-09-30 | -$61.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$31.00K 10-Q · filed 2021-11-15 | |||||||
| 2020-06-30 | $30.00K 10-Q · filed 2021-08-16 | ||||||||
| 2019-12-31 | $123.00K 10-K · filed 2022-03-30 |